Ascend Wellness Holdings (AAWH) Shares Outstanding (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Shares Outstanding (Entity) of $202.8 million for Q1 2026, down 1.17% year-over-year from $205.2 million in Q1 2025, and little changed quarter-over-quarter from $202.2 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Shares Outstanding (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $202.8 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) fell 1.17% year-over-year to $202.8 million; the TTM figure through Mar 2026 stood at $202.8 million (down 1.17% YoY), while the FY2025 annual figure was $202.2 million, down 1.37% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $202.8 million, roughly flat from $202.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $214.4 million in Q3 2024, with the low at $174.5 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $203.3 million (2025), against an average of $200.4 million.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) jumped 63.9% in 2022, then fell 5.5% in 2025.
- Ascend Wellness Holdings' Shares Outstanding (Entity) stood at $188.1 million in 2022, then climbed by 10.0% to $206.9 million in 2023, then fell by 0.89% to $205.0 million in 2024, then fell by 1.37% to $202.2 million in 2025, then advanced by 0.3% to $202.8 million in 2026.
- Business Quant data shows AAWH's Shares Outstanding (Entity) at $202.8 million in Q1 2026, $202.2 million in Q4 2025, and $202.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 832.44 Mn |
| 10 | Ascend Wellness Holdings | 97.42 Mn | 30.42 Mn | 45.49 Mn | 203.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 202.45 Mn |
| Mar 31, 2026 | 202.45 Mn |
| Dec 31, 2025 | 203.48 Mn |
| Sep 30, 2025 | 202.97 Mn |
| Jun 30, 2025 | 203.87 Mn |
| Mar 31, 2025 | 205.00 Mn |
| Dec 31, 2024 | 212.43 Mn |
| Sep 30, 2024 | 214.29 Mn |
| Jun 30, 2024 | 213.16 Mn |
| Mar 31, 2024 | 208.95 Mn |
| Dec 31, 2023 | 199.15 Mn |
| Sep 30, 2023 | 205.71 Mn |
| Jun 30, 2023 | 195.65 Mn |
| Mar 31, 2023 | 188.49 Mn |
| Dec 31, 2022 | 183.38 Mn |
| Sep 30, 2022 | 187.70 Mn |
| Jun 30, 2022 | 185.31 Mn |
| Mar 31, 2022 | 172.49 Mn |
| Dec 31, 2021 | 149.43 Mn |
| Sep 30, 2021 | 169.88 Mn |